Bone Scan Index (BSI) of bone scintigraphy and detection of circulate tumor cells (CTC) are strong predictive factors on effectiveness of enzalutamide for castration-resistant prostate cancer with bone metastases-MedSci.cn

Bone Scan Index (BSI) of bone scintigraphy and detection of circulate tumor cells (CTC) are strong predictive factors on effectiveness of enzalutamide for castration-resistant prostate cancer with bone metastases

Nagata, M; Hirano, H; Nagaya, N; Horie, S

INTERNATIONAL JOURNAL OF UROLOGY, 2022; 29 (): 37

科室
- - 订阅+
  - 更多科室
工具
服务